Targinact 2,5 mg - 1,25 mg tabl. prol.-rel.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Oxycodone Hydrochloride 2,5 mg - Eq. Oxycodone 2,25 mg; Naloxone Hydrochloride 1,25 mg - Eq. Naloxone 1,13 mg

Disponible depuis:

Mundipharma BV-SRL

Code ATC:

N02AA55

DCI (Dénomination commune internationale):

Oxycodone Hydrochloride; Naloxone Hydrochloride

Dosage:

2,5 mg - 1,25 mg

forme pharmaceutique:

Prolonged-release tablet

Composition:

Oxycodone Hydrochloride 2.5 mg; Naloxone Hydrochloride 1.25 mg

Mode d'administration:

Oral use

Domaine thérapeutique:

Oxycodone, Combinations

Descriptif du produit:

CTI code: 451591-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-03 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-02 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-05 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-04 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-07 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-06 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-09 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-08 - Pack size: 60 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 451591-10 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: No

Date de l'autorisation:

2014-02-28